Walstir Fonseca
Internal Medicine · Lindon, UTNPI 1013933506
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 174 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 16.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,516 and has fallen 99.0% since, to $15 in 2022.
Across 174 payments — averaging $13.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$383
- Boehringer Ingelheim$294
- Pfizer$254
- AstraZeneca$164
- Johnson & Johnson$154
- GSK$144
- plus $964 from 25 others
What the payments were for
- Food & beverage$2,357100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 26 | $383 |
| Boehringer Ingelheim | 18 | $294 |
| Pfizer | 24 | $254 |
| AstraZeneca | 12 | $164 |
| Johnson & Johnson | 15 | $154 |
| GSK | 10 | $144 |
| Sanofi-aventis U.S. LLC | 8 | $122 |
| Mylan Specialty L.p. | 7 | $113 |
| Lilly USA, LLC | 7 | $91 |
| Novartis | 4 | $60 |
| Teva Pharmaceuticals USA, Inc. | 4 | $59 |
| Sunovion Pharmaceuticals Inc. | 6 | $59 |
| Novo Nordisk | 4 | $49 |
| Arbor Pharmaceuticals, Inc. | 3 | $39 |
| Ironwood Pharmaceuticals, Inc | 3 | $37 |
| Therapeuticsmd, Inc. | 2 | $36 |
| Biohaven Pharmaceuticals, Inc. | 2 | $31 |
| Actelion Pharmaceuticals US, Inc. | 2 | $30 |
| Merck | 2 | $29 |
| Astellas Pharma US Inc | 2 | $27 |
| Medtronic(2 entities) | 2 | $24 |
| GE HealthCare | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 2 | $22 |
| Endo Pharmaceuticals Inc. | 1 | $19 |
| Sanofi Pasteur Inc. | 1 | $16 |
| Amgen | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| Antares Pharma, Inc. | 1 | $14 |
| Boston Scientific | 1 | $12 |
| Esperion Therapeutics, Inc. | 1 | $12 |
| Eisai Inc. | 1 | $11 |
How this compares
$2,357 in reported general payments places this provider in the 80th percentile of 496 internal medicine providers in Utah.
Other internal medicine in Lindon
- Willard DereSalt Lake City$4.7M
- Kenneth SchaecherWest Valley City$333K
- Steven CallSpringville$178K
- James ChamberlainSalt Lake City$106K
- Alexander PastuszakSalt Lake City$87K
- Zameer AbedinSalt Lake City$83K
- Kashif MemonVernal$73K
- Barbara RizzardiSandy$30K
- Gerald GleichSalt Lake City$22K
- Brian HornerSalt Lake City$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.